The Opportunity Cost of Capital
The opportunity cost of the capital invested in pharmaceutical research and development (R&D) to bring a new drug to market makes up as much as half the total cost. However, the literature on the cost of pharmaceutical R&D is mixed on how, exactly, one should calculate this "hidden"...
Saved in:
Main Authors: | Ayman Chit PhD (Author), Ahmad Chit CA (Author), Manny Papadimitropoulos PhD (Author), Murray Krahn MD (Author), Jayson Parker PhD (Author), Paul Grootendorst PhD (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2015-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Merger & Acquisition and Capital Expenditure in Health Care
by: Wenjing Ouyang PhD, et al.
Published: (2017) -
Costs Related to Diverting Ileostomy After Rectal Cancer Surgery: A Population-Based Healthcare Cost Analysis Based on Nationwide Registers
by: Ursula Dahlstrand PhD, MD, et al.
Published: (2023) -
Capital Investment by Independent and System-Affiliated Hospitals
by: Nathan W. Carroll PhD, et al.
Published: (2015) -
Social Capital Mediates the Relationship between Social Distancing and COVID-19 Prevalence in Japan
by: Keisuke Kokubun PhD, et al.
Published: (2021) -
Cost-Effectiveness Threshold for Healthcare: Justification and Quantification
by: Moshe Yanovskiy PhD, et al.
Published: (2022)